Who owns TG Therapeutics (TGTX)? Superinvestor holders
2 superinvestors of the 157 tracked here hold TG Therapeutics (TGTX) in their latest 13F filing, with $33M between them. Ray Dalio (founder) gives it the most weight: 0.14% of the reported portfolio. In their latest reported quarter, Larry Robbins opened a position; Ray Dalio (founder) added.
Among the 156 filings in for Q3 2026, 2 investors held it; in Q4 2024, with the same number of filings on file, 0 did.
Key facts
- Superinvestors holding it
- 2 of 157
- Biggest holder
- Ray Dalio (founder), $32.7M
- Largest weight
- Ray Dalio (founder), 0.14%of their portfolio
- Combined value
- $33M
- Bought last quarter
- 2
- Sold last quarter
- 0
From each investor's latest 13F filing: 156 investors report Q3 2026, 1 investor reports Q2 2026. Latest filing in this set: Nov 17, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Ray Dalio (founder)Bridgewater Associates | 0.14% | $32.7M | 586.63K | ▲ Added 36% | +156.74K | Q3 2026 |
| 2 | Larry RobbinsGlenview Capital Management | 0.01% | $267.7K | 4.8K | New | +4.8K | Q3 2026 |
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 156 | 2 | 591.43K | $33M | 2 | 0 |
| Q2 2026 | 157 | 0 | — | — | 0 | 0 |
| Q1 2026 | 157 | 0 | — | — | 0 | 0 |
| Q4 2025 | 157 | 0 | — | — | 0 | 0 |
| Q3 2025 | 157 | 0 | — | — | 0 | 1 |
| Q2 2025 | 157 | 0 | — | — | 0 | 0 |
| Q1 2025 | 156 | 0 | — | — | 0 | 0 |
| Q4 2024 | 156 | 0 | — | — | 0 | 0 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Ray Dalio (founder) | 586.63K | — | — | — | — | — | — | — |
| Larry Robbins | 4.8K | — | — | — | — | — | — | — |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own TGTX?
In their latest 13F filings: Ray Dalio (founder) (0.14% of the portfolio, $32.7M), Larry Robbins (0.01% of the portfolio, $267.7K).
Who bought TGTX last quarter?
Ray Dalio (founder) (added 36%), Larry Robbins (new position). “Last quarter” is each investor's latest reported quarter.
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 17, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns TG Therapeutics (TGTX)? Superinvestor holders”, data as of 17 November 2026. https://funkfolio.com/stock/TGTX/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to TGTX by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.